MedTrace Logo

Coherex WAVECREST I Left Atrial Appendage Occlusion Study

NCT02239887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2015-01-15

No results posted yet for this study

Summary

Purpose To establish the safety and efficacy of the Coherex WaveCrest Left Atrial Appendage Occlusion System for left atrial appendage (LAA) closure during treatment of non-valvular atrial fibrillation in patients who are at increased risk for embolic stroke and have an ongoing indication for oral anticoagulation.

Conditions

  • Non-valvular Paroxysmal, Persistent, or Permanent Atrial Fibrillation
  • LAA Anatomy Amenable to Treatment by Percutaneous Technique
  • Anticoagulation Indication for Potential Thrombus Formation in the Left Atrium

Interventions

DEVICE

WaveCrest LAA occlusion device

Left Atrial Appendage Occlusion

Sponsors & Collaborators

  • Coherex Medical

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2014-11-30
Completion
2014-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02239887 on ClinicalTrials.gov